Drug Database
Back to search

Netherlands· NL-95475bad0f80

Burinex 0,5 mg/ml, oplossing voor injectie

A bumetanide product containing bumetanide, registered in Netherlands by Karo Pharma AB. The same ATC class is registered in 10 of our 19 countries.

ATC C03CA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBurinex 0,5 mg/ml, oplossing voor inj…ATCC03CA02REGISTER NO.NL-95475bad0f80PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bumetanideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bumetanide is registered in 10 of 19 countries.

Countries holding a registration under ATC C03CA02 (bumetanide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search bumetanide products by name

Bumetanide · ATC C03CA02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bumetanide costs, country by country.

Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Bumetanide · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • FR France$0.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BUMETANIDE
Manufacturer
Karo Pharma AB
Country
Netherlands (NL)
ATC code
C03CA02
ATC class
Bumetanide
Defined daily dose
1 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    12412

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

318 interactions on record for bumetanide.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bumetanide against other medicinesHow interaction checks work

Bumetanide · interactions on record

318 records

  • 15 severe
  • 177 moderate
  • 9 minor
  • 116 info

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bumetanide in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bumetanide products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Burinex
  • Belgium · Burinex
  • Denmark · Burinex
  • Spain · Fordiuran
  • France · Burinex
  • United Kingdom (Northern Ireland) · Bumetanide Generics Uk, Bumetanide Niche Generics
  • Greece · Burinex
  • Ireland · Burinex
  • Luxembourg · Burinex
  • Malta · Burinex
  • Norway · Burinex
  • Sweden · Burinex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/45cd8bbe-5b62-4b26-b0da-4d215288862e
GET /v1/drugs/45cd8bbe-5b62-4b26-b0da-4d215288862e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h12412_smpc.pdf",
  "strength": null,
  "atc_label": "Bumetanide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg12412",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "WATER VOOR INJECTIE",
    "XYLITOL (E 967)"
  ],
  "substances": [
    "BUMETANIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h12412.pdf",
  "authorised_at": "1988/05/20",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "12412",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about bumetanide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console